SWITCHING INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB WAS SAFE AND SUCCESSFUL SHORT TERM IN ULCERATIVE COLITIS AND CROHN PATIENTS – A BELGIAN SINGLE CENTER EXPERIENCE
Leander Cornelis 1
Evva De Jonckere 1
Emma Lernout 1
Jelle Bossuyt 1
Hilde Vanpoucke 1
Dominiek De Wulf 1
Lobke Desomer 1
Filip Baert 1
1 AZ Delta, Roeselare, Belgium
Session
IBD (Posters)
Conference
UEG Week Vienna 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]